Dyno Therapeutics

Empowering a diverse team of the best problem-solvers to drive cutting-edge science toward improving patient health.

Dyno Therapeutics is pioneering an artificial intelligence (AI) powered approach to gene therapy. Using machine learning and quantitative high-throughput in vivo experimentation, we are inventing new ways to design adeno-associated virus (AAV), the most widely-used vector for gene therapies. Our team includes world-class molecular and synthetic biologists, protein engineers and gene therapy scientists working alongside software engineers, data scientists, and AI and machine learning experts to enhance the life-changing potential of gene therapies for millions of patients.

Obvious Ventures